RxDoctor Payments Data

Christopher Moran, MD

Neuroradiology · Saint Louis, MONPI 1124046859

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $398,289 of the $661,575 with a category attached, or 60.2%. 7 manufacturers reported payments, led by Microvention, Inc. at 54.0% of the total. Reporting peaked in 2021 at $168,871 and has fallen 99.9% since, to $137 in 2025. Among neuroradiology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$661,575in general payments, 2019–2025

Across 639 payments — averaging $1035.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$357K
  • Medtronic$118K
  • Medical Device Business Services, Inc.$97K
  • Stryker$89K
  • Johnson & Johnson$554
  • Siemens Medical Solutions USA, Inc.$144
  • plus $112 from 1 others
$11,645in research payments, 2019–2025

Across 4 payments — averaging $2911.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Siemens Medical Solutions USA, Inc.$8K
  • Microvention, Inc.$3K

What the payments were for

  • Consulting fees$179,50427%
  • Speaking & faculty fees$398,28960%
  • Travel & lodging$70,86911%
  • Food & beverage$12,9132%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$661,575 in reported general payments places this provider in the 95th percentile of 20 neuroradiology providers in Missouri.

See all neuroradiology providers in Missouri

Medicare billing

Part B allowed, 2024
$19,675
Medicare patients
19
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor15$4,820

Paid to pharmacies, not to this prescriber.

Other neuroradiology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →